BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9986794)

  • 1. Sp1 is involved in a protein kinase C-independent activation of human T cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate.
    Torgeman A; Mor-Vaknin N; Aboud M
    Virology; 1999 Feb; 254(2):279-87. PubMed ID: 9986794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C.
    Torgeman A; Mor-Vaknin N; Zelin E; Ben-Aroya Z; Löchelt M; Flügel RM; Aboud M
    Virology; 2001 Mar; 281(1):10-20. PubMed ID: 11222091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different molecular mechanisms of HTLV-1 and HIV LTR activation by TPA.
    Jabareen A; Suleman M; Abu-Jaafar A; Huleihel M
    Biochem Biophys Res Commun; 2018 Jun; 500(3):538-543. PubMed ID: 29660338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways.
    Mor-Vaknin N; Torgeman A; Galron D; Löchelt M; Flügel RM; Aboud M
    Virology; 1997 Jun; 232(2):337-44. PubMed ID: 9191847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines.
    Abou-Kandil A; Chamias R; Huleihel M; Godbey WT; Aboud M
    PLoS One; 2012; 7(1):e29934. PubMed ID: 22299029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I-infected T-cells from apoptosis by the viral tax protein.
    Torgeman A; Ben-Aroya Z; Grunspan A; Zelin E; Butovsky E; Hallak M; Löchelt M; Flügel RM; Livneh E; Wolfson M; Kedar I; Aboud M
    Exp Cell Res; 2001 Nov; 271(1):169-79. PubMed ID: 11697893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.
    Clark NM; Smith MJ; Hilfinger JM; Markovitz DM
    J Virol; 1993 Sep; 67(9):5522-8. PubMed ID: 8350410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory elements involved in tax-mediated transactivation of the HTLV-I LTR.
    Seeler JS; Muchardt C; Podar M; Gaynor RB
    Virology; 1993 Oct; 196(2):442-50. PubMed ID: 8372429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of HTLV-1 LTR activation by TPA varies in different human T-cell lines: role of specific PKC isoforms.
    Chamias R; Huleihel M; Aboud M
    Leuk Res; 2010 Jan; 34(1):93-9. PubMed ID: 19406475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1 tax-induced NF-kappaB activation is synergistically enhanced by 12-O-tetradecanoylphorbol-13-acetate: mechanism and implications for Tax oncogenicity.
    Azran-Shaish I; Tabakin-Fix Y; Huleihel M; Bakhanashvili M; Aboud M
    J Mol Med (Berl); 2008 Jul; 86(7):799-814. PubMed ID: 18425496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human T-cell leukemia virus type 1 gene expression by Sp1 and Sp3 interaction with TRE-1 repeat III.
    Yao J; Grant C; Harhaj E; Nonnemacher M; Alefantis T; Martin J; Jain P; Wigdahl B
    DNA Cell Biol; 2006 May; 25(5):262-76. PubMed ID: 16716116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sp family members preferentially interact with the promoter proximal repeat within the HTLV-I enhancer.
    Wessner R; Yao J; Wigdahl B
    Leukemia; 1997 Apr; 11 Suppl 3():10-3. PubMed ID: 9209281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The high-affinity Sp1 binding site in the HTLV-1 promoter contributes to Tax-independent basal expression.
    Livengood JA; Nyborg JK
    Nucleic Acids Res; 2004; 32(9):2829-37. PubMed ID: 15155851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells.
    Yamagata T; Mitani K; Ueno H; Kanda Y; Yazaki Y; Hirai H
    Mol Cell Biol; 1997 Aug; 17(8):4272-81. PubMed ID: 9234684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bZIP transcription factor ATFx binds human T-cell leukemia virus type 1 (HTLV-1) Tax and represses HTLV-1 long terminal repeat-mediated transcription.
    Forgacs E; Gupta SK; Kerry JA; Semmes OJ
    J Virol; 2005 Jun; 79(11):6932-9. PubMed ID: 15890932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the human T-cell leukemia virus type I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate and by tax (p40x) occurs through similar but functionally distinct target sequences.
    Radonovich M; Jeang KT
    J Virol; 1989 Jul; 63(7):2987-94. PubMed ID: 2786091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer-binding proteins modulate human T cell leukemia virus type 1 long terminal repeat activation.
    Grant C; Nonnemacher M; Jain P; Pandya D; Irish B; Williams SC; Wigdahl B
    Virology; 2006 May; 348(2):354-69. PubMed ID: 16458341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.
    Gitlin SD; Dittmer J; Shin RC; Brady JN
    J Virol; 1993 Dec; 67(12):7307-16. PubMed ID: 8230454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
    Connor LM; Oxman MN; Brady JN; Marriott SJ
    Virology; 1993 Aug; 195(2):569-77. PubMed ID: 8337832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new regulatory element that augments the Tax-dependent enhancer of human T-cell leukemia virus type 1 and cloning of cDNAs encoding its binding proteins.
    Tanimura A; Teshima H; Fujisawa J; Yoshida M
    J Virol; 1993 Sep; 67(9):5375-82. PubMed ID: 8350401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.